BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22972438)

  • 21. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
    Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA
    Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
    Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
    Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.
    Jöhrer K; Zelle-Rieser C; Perathoner A; Moser P; Hager M; Ramoner R; Gander H; Höltl L; Bartsch G; Greil R; Thurnher M
    Clin Cancer Res; 2005 Apr; 11(7):2459-65. PubMed ID: 15814620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.
    Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H
    Biochem Biophys Res Commun; 2007 Nov; 363(3):542-6. PubMed ID: 17889832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KLF9 inhibits the proliferation, invasion, and migration of renal cell carcinoma through the SDF-1/CXCR4 axis.
    Yu P; Cheng L; Xia WM; Liu DY; Yu JS; Zhou YF; Zheng YJ
    Kaohsiung J Med Sci; 2023 Jun; 39(6):587-595. PubMed ID: 37010151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of CXCR4 inhibits the proliferation, adhesion, chemotaxis and invasion of salivary gland mucoepidermoid carcinoma Mc3 cells in vitro.
    Wen DS; Zhu XL; Guan SM; Wu YM; Yu LL; Wu JZ
    Oral Oncol; 2008 Jun; 44(6):545-54. PubMed ID: 17936060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
    Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
    Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
    Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
    Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4.
    Ok S; Kim SM; Kim C; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):768-78. PubMed ID: 22299827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells.
    Hong JS; Pai HK; Hong KO; Kim MA; Kim JH; Lee JI; Hong SP; Hong SD
    J Oral Pathol Med; 2009 Feb; 38(2):214-9. PubMed ID: 18624931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
    Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S
    Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.